Cytek BioSciences, Inc. (CTKB) Social Stream
CYTEK BIOSCIENCES INC (CTKB) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CTKB.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 2 | $27 | $27 | $27 | $6.4 | 321.88% |
| 2022-01-06 | 3 | $27 | $20 | $23.5 | $6.4 | 267.19% |
| 2022-02-25 | 3 | $20 | $18 | $19 | $6.4 | 196.87% |
| 2022-02-28 | 3 | $18 | $17 | $17.5 | $6.4 | 173.44% |
| 2022-05-12 | 3 | $17 | $11 | $14 | $6.4 | 118.75% |
| 2022-05-16 | 3 | $12 | $11 | $11.5 | $6.4 | 79.69% |
| 2022-07-19 | 4 | $15 | $11 | $12.666 | $6.4 | 97.91% |
| 2022-08-12 | 4 | $17 | $12 | $14.666 | $6.4 | 129.16% |
| 2022-11-10 | 3 | $17 | $15 | $16 | $6.4 | 150% |
| 2022-11-13 | 3 | $18 | $15 | $16.666 | $6.4 | 160.41% |
| 2022-11-14 | 3 | $17 | $15 | $16.333 | $6.4 | 155.2% |
| 2022-12-14 | 4 | $17 | $15 | $16.5 | $6.4 | 157.81% |
| 2023-03-02 | 4 | $17 | $14 | $15.5 | $6.4 | 142.19% |
| 2023-03-06 | 4 | $17 | $14 | $15 | $6.4 | 134.37% |
| 2023-04-11 | 4 | $17.001 | $14 | $15 | $6.4 | 134.37% |
| 2023-06-28 | 4 | $17.001 | $12 | $14.25 | $6.4 | 122.66% |
| 2023-08-15 | 5 | $17.001 | $12 | $14.25 | $6.4 | 122.66% |
The Trend in the Analyst Price Target
Over the past 148 days, CTKB's average price target has gone down $0.75.
Over the past 40 weeks, CTKB's average upside potential has been 49.43%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-12-14 | 4 | 17.000 | 15 | 16.500 | 11.46 | 43.98% |
| 2023-03-06 | 4 | 15.000 | 14 | 14.333 | 10.15 | 41.21% |
| 2023-03-20 | 4 | 17.001 | 14 | 15.000 | 9.15 | 63.93% |
| 2023-04-11 | 4 | 17.001 | 14 | 15.000 | 9.55 | 57.07% |
| 2023-06-28 | 5 | 17.001 | 12 | 14.250 | 8.09 | 76.14% |
CTKB Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.8 | 3 | 0 | 2 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
CTKB's average broker recommendation rating worsened by 0.13 over the prior 39 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CTKB as an investment opportunity.
- CTKB has a higher number of analysts covering the stock than 216.94% of all US stocks.
- CTKB has a greater average analyst price target than 241.61% of Measuring and Control Equipment stocks.
- CYTEK BIOSCIENCES INC's variance in analysts' estimates is lower than -162.1% of Healthcare stocks.
- In the context of Measuring and Control Equipment stocks, CYTEK BIOSCIENCES INC's upside potential (average analyst target price relative to current price) is greater than 1617.32% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Measuring and Control Equipment industry with the ratings most similar to CYTEK BIOSCIENCES INC are BNGO, SEER, and ITRI.
View All Top Stocks by Price Target
Is CTKB a Buy, Hold or Sell? See the POWR Ratings now!